[Use of BCG in superficial urinary bladder carcinoma].
Böhle
A
A
Klinik für Urologie, Medizinische Universität, Ratzeburger Allee 160, 23538 Lübeck. boehle@medinf.mu-luebeck.de
Durek
C
C
D001500:BCG Vaccine / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D006801:Humans; D009367:Neoplasm Staging; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology
D001500:BCG Vaccine